About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
COVID-19
New Therapies and Current Patient Management of Lymphomas
Update on Patient Care Treatment Strategies in Leukemia
Controversies and Update for Patient Care in Multiple Myeloma
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
bsAb and IO for R/R MM in 2021: Are Teclistamab, Talquetamab, & Cevostamab Showing Promising Activity?
By
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
FEATURING
Adam D. Cohen
By
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
FEATURING
Adam D. Cohen
24 views
March 2, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
23:35
University of Colorado Division of Hematology
2024 Updates in PV/ET
Feat.
B. McMahon
Featured Video
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
Controversies and Update for Patient Care in Multiple Myeloma
17:23
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
UPenn Expert Analysis 40 y/o Patient With MM: How to Treat Systemica…
Feat.
E. Stadtmauer,
D. Vogl,
A. Cohen,
S. Wallace
10:17
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
UPenn Physicians Analyze a Challenging Case of MM: What Systemic The…
Feat.
E. Stadtmauer,
D. Vogl,
A. Cohen,
S. Wallace
15:36
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
CAR-T and IO for R/R MM in 2021: Is bb2121 Safe and Does It Improve …
Feat.
A. Cohen
15:36
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
bsAb and IO for R/R MM in 2021: Are Teclistamab, Talquetamab, & …
Feat.
A. Cohen
22:31
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
2021 Experimental Therapies for Relapsed Myeloma: Antibodies (Dara, …
Feat.
D. Vogl